Caricamento...

Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients

BACKGROUND—More than 50% of patients with Parkinson's disease develop motor response fluctuations (the "wearing off" phenomenon) after more than five years of levodopa therapy. Inhibition of catechol-O-methyltransferase by tolcapone has been shown to increase levodopa bioavailability...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Baas, H, Beiske, A, Ghika, J, Jackson, M, Oertel, W, Poewe, W, Ransmayr, G
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 1997
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2169755/
https://ncbi.nlm.nih.gov/pubmed/9343116
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !